Cargando…
Synthetic Glycolipids as Molecular Vaccine Adjuvants: Mechanism of Action in Human Cells and In Vivo Activity
[Image: see text] Modern adjuvants for vaccine formulations are immunostimulating agents whose action is based on the activation of pattern recognition receptors (PRRs) by well-defined ligands to boost innate and adaptive immune responses. Monophosphoryl lipid A (MPLA), a detoxified analogue of lipi...
Autores principales: | Facchini, Fabio A., Minotti, Alberto, Luraghi, Andrea, Romerio, Alessio, Gotri, Nicole, Matamoros-Recio, Alejandra, Iannucci, Andrea, Palmer, Charys, Wang, Guanbo, Ingram, Rebecca, Martin-Santamaria, Sonsoles, Pirianov, Grisha, De Andrea, Marco, Valvano, Miguel A., Peri, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404200/ https://www.ncbi.nlm.nih.gov/pubmed/34382796 http://dx.doi.org/10.1021/acs.jmedchem.1c00896 |
Ejemplares similares
-
Synthetic glycolipid-based TLR4 antagonists negatively regulate TRIF-dependent TLR4 signalling in human macrophages
por: Palmer, Charys, et al.
Publicado: (2021) -
The synthetic glycolipid-based TLR4 antagonist FP7 negatively
regulates in vitro and in vivo haematopoietic
and non-haematopoietic vascular TLR4 signalling
por: Palmer, Charys, et al.
Publicado: (2018) -
New Glucosamine-Based
TLR4 Agonists: Design, Synthesis,
Mechanism of Action, and In Vivo Activity as Vaccine Adjuvants
por: Romerio, Alessio, et al.
Publicado: (2023) -
Cleaner synthesis of preclinically validated vaccine adjuvants
por: Romerio, Alessio, et al.
Publicado: (2023) -
Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties
por: Cochet, Florent, et al.
Publicado: (2019)